Case Report
It Is All in the Genes: A Story of Unexpected Survival in a 67-Year-Old Male with Metastatic Pancreatic Cancer
Table 1
CA19-9 levels and corresponding treatment course.
(a) |
| | Year | 2019 | | Month | Aug | Sept | Oct | Nov | Dec |
| | CA19-9 | 37 | — | — | — | 54 | | Treatment | NT | NT | NT | NT | NT |
|
|
(b) |
| | Year | 2020 | | Month | Jan | Feb | Mar | Apr | May | June | July | Aug | Sept | Oct | Nov | Dec |
| | CA19-9 | 44 | — | 52, 56 | — | 61 | 59 | 62 | — | 118 | 126 | — | — | | Treatment | GA | GA | GA | FFX | FFX | FFX | GTX | GTX | NT | NT | NT | NT |
|
|
(c) |
| | Year | 2021 | | Month | Jan | Feb | Mar | Apr | May | June | July | Aug | Sept | Oct | Nov | Dec |
| | CA19-9 | — | — | — | — | 59 | — | — | 99 | — | 81 | — | 131, 146 | | Treatment | NT | NT | NT | NT | NT | NT | NT | NT | NT | GTX | GTX | GTX |
|
|
(d) |
| | Year | 2022 | | Month | Jan | Feb | Mar | Apr | May | June | July | Aug | Sept | Oct | Nov | Dec |
| | CA19-9 | 84 | 117 | 87, 135 | 86 | 54 | 192 | 282 | 64 | 78 | — | — | — | | Treatment | GTX | GTX | GTX | GTX | GTX | NT | NT | NT | NT | GTX | GTX | GC |
|
|
NT: no treatment; GA: gemcitabine, abraxane; FFX: FOLFIRINOX: 5-fluorouracil, leucovorin, irinotecan, oxaliplatin; GTX: gemcitabine, docetaxel, capecitabine; GC: gemcitabine, cisplatin.
|
